Opiates + NSAIDS Flashcards
Opioid agonists
- natural alkaloids
- synthetic opioids
Natural alkaloids –> morphine + codeine
Synthetic opiods
- meperidine
- fentanyl, sufentanil, alfentanil, remifentanil
- methadone
Opioid agonists - basic principles
Act at stereospecific opioid receptors
- presynaptic and post synaptic sites in the CNS
- principally brainstem and spinal cord
- activation of opioid receptors on primary afferent neurons
- affinity for receptors correlates with potency
The same receptors are normally activated by endogenous peptides = endorphins –> opioids mimic endorphins
Opioid receptor locations + roles
Brain
- periaqueductal gray matter in the brainstem
- amygdala
- corpus striatum
- hypothalamus
Spinal cord –> substantia gelatinosa
Roles
- Involved with pain perception
- Integration of pain impulses-
- Pain responses
Sites of opioid drug action
- thalamus
- PAG
- rostral ventral medulla
- dorsal horn
- peripheral tissue
Opioid receptor activation and mechanism
Activation
- results in decrease in neurotransmission
- largely by presynaptic inhibition of NT release –> ach, dopamine, NE, substance P
Mechanism
- Pre-synaptic –> Mu is a g-protein coupled receptor = inhibits adenylyl cyclase
- activation results in decreased conductance of voltage gated calcium channels –> decreased transmitter release –> prevents pain transmission - Post synaptic –> activation of Mu receptor increases K outflow postsynaptically = hyperpolarizes the membrane potential –> prevents excitation and prolongation of action potential = decreased neuronal activity
Classification of opioid receptors
3 classes of opioid receptors = mu, delta, kappa
- these receptors function as a pain suppression system
Mu receptors –> most important
- underlie most analgesia
- some unwanted effects = respiratory depression, GI, euphoria, depression, constipation, physical dependence, sedation
Delta receptors –> contribute to analgesia
Kappa receptors –> contribute to spinal analgesia
- unwanted side effects = constipation, miosis, psych, sedation
Opioid effects - CNS
- Analgesia –> acts on dorsal spinal cord, PAG, dorsal raphe nucleus, limbic system
- sedation
- respiratory system –> normally if the CO@ is too high or O2 is too low, a signal is sent to the brainstem to stimulate ventilation –> this is blunted by narcotics
- –> dose dependent depression
- –> direct depressant effect on brainstem ventilation centers
- –> loss of CO2 responsiveness
- –> retain hypoxic drive
Opioid effects
- antitussive (cough suppression)
- muscle rigidity
- miosis
Antitussive –> by effects on medullary cough centers
- D-methorphan, codeine
Muscle rigidity –> related to actions at opioid receptors and interaction within corpus striatum and substantia niagra - inhibit DA release
- large doses
- rapid injection
Miosis –> due to excitatory action at edinger-westphal nucleus
- no tolerance to this effect
- antagonized by atropine
Opoid effects
- cardiovascular system
- Nausea and emesis
Myocardium is generally unaffected in normal individuals
Hypotension occurs due to
- bradycardia from decreased central sympathetic tone
- increased activity over vagal nerves
- direct depressant effect on SA node
- histamine release
Nausea and emesis –> caused by direct stimulation of CTZ in 4th ventricle
- due to opioid dopamine agonism
Opioid effects - GI
Stomach and intestines
- decreased peristalsis, increased sphincter tone (decreased Ach)
- constipation –> delayed passage allows for water reabsorption = constipation
- gallbladder –> sphincter of oddi narrowing + increased biliary pressure
Opioid effects
- GU
- skin
- placenta
GU
- increased tone and peristalsis of ureter
- tone of vesicle sphincter is enhanced
- urinary retention
Skin
- histamine release
- cutaneous vasodilation
- urticaria
Placenta –> not a barrier for transfer
- neonatal ventilatory depression can occur
- neonatal dependence is a possibility
Morphine
Prototype opioid agonist
- analgesia, euphoria, sedation
- modifies pereception of noxious stimulation
- no longer perceived as pain
- onset –> 15-30 minutes
- peak effects (blood to brain) –> 45-90 min
- duration –> 4 hours
- delay in penetrance of BBB –> so analgesic and ventilatory effects may not correlate with initial high plasma levels
CNS penetration poor
- poor lipid solubility
- high degree of ionization
- protein binding
- rapid conjugation
Metabolism
- conjugation with glucoronic acid
- hepatic and extra hepatic sites –> 2 metabolites
- 75-85% M3G = inactive metabolite
- 15-25% M6G = active metabolite –> more potent than morphine
- metabolites removed principally in urine –> important if renal failure
- limited biliary excretion
M6G –> analgesia, respiratory depression due to action at mu receptors
- removal impaired in renal failure
- unexpected ventilatory depressant effects
Meperidine
Synthetic opioid agonist
- shares local anesthetic features
- structurally similar to atropine
Pharmacokinets
- 1/10 as potent as morphine
- duration 2-4 hours
- N-demethylated to normeperidine in liver
- Normeperidine –> myoclonus, seizures
- especially in renal impairment
Uses –> post operative shivering (stimulate kappa receptors
Meperidine - side effects
- large doses decrease myocardial contractility
- mydriasis, tachycardia –> due to atropine effects
- seizures
- histamine release
Fentanyl
Structurally related to meperidine
- 75-125 more potent than morphine
Pharmacokinetics
- more rapid but shorter duration than morphine
- greater lipid solubility
- rapid redistribution to inactive sites
Metabolites –> minimally active
No myocardial depression or histamine release
Sufentanil
5-10 times as potent as fentanyl –> greater affinity for opioid receptors
Lipophilic
- rapidly crosses BBB = fast onset CNS effects
- rapid redistribution
- extensive protein binding so smaller volume of distribution
Metabolism
- rapidly metabolized
- metabolites are inactive
Longer duration of analgesia
